The reproducibility of repeat measures of airway inflammation in stable atopic asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1457-1461

  Faul, John L ^b   Demers, Elizabeth A ^b   Burke, Conor M ^b   Poulter, Leonard W ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MALE; MEMORY CELL; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE;

EID: 0032697763     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9812027     Document Type: Article

References (22)

1. Faul, J. L., C. T. Leonard, C. M. Burke, V. J. Tormey, and L. W, Poulter. 1998. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time. Thorax 53:753-761.
2. Frew, A. J., J. St.-Pierre, L. M. Teran, A. Trefilieff, J. Madden, D. Peroni, K. M. Bodey, A. F. Walls, P. H. Howarth, M. P. Carroll, and S. T. Holgate. 1996. Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J. Allergy Clin. Immunol. 98:133-143
3. Burke, C., S. Sreenan, S. Pathmakanthan, J. Patterson, B. Schmekel, and L. W. Poulter. 1996. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study. Thorax 51:493-999.
4. Trigg, C.J., N. D. Manolitsas, J.H. Wang, M. A. Calderon, A. McAuley, S. E. Jordan, et al. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroid in asthma. Am. J. Respir. Crit. Care Med. 150:17-22.
5. American Thoracic Society. 1987. Guidelines for the diagnosis and treatment of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
6. Armitage, P., and G. Berry. 1996. Measurement error and correlation coefficients. Br. Med. J. 313:41-42.
7. Sullivan, P., D. Stephens, T. Ansari, J. Costello, and P. Jeffery. 1998. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur. Respir. J. 12:811-815.
8. Haley, K. J., M. E. Sunday, B. R. Wiggs, H. P. Kozakewich, J. J. Reilly, S. J. Mentzer, D. J. Sugarbaker, C. M. Doerschuk, and J. M. Drazen. 1998. Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 158:565-572.
9. Sont, J. K., L. N. A. Willems, C. E. Evertse, R. Hooijer, P. J. Sterk, and J. H. van Krieken. 1997. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma. Eur. Respir. J. 10:2602-2608.
10. Richmond, I., H. Booth, C. Ward, and E. Haydn-Walters. 1996. Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma. Am. J. Respir. Crit. Care Med. 153:899-903.
11. Faul, J. L., V. J. Tormey, C. Leonard, C. M. Burke, J. Farmer, S. J. Home, and L. W. Poulter. 1997. Lung immunopathology in cases of sudden asthma death. Eur. Respir. J. 10:301-307.
12. Chinn, S. 1991. Statistics in respiratory medicine: 2. Repeatability and method comparison. Thorax 46:432-434.
13. Sterk, P. J., L. M. Fabbri, P. H. Quanjer, D. W. Cockcroft, P. M. O'Byrne, S. D. Anderson, E. F. Juniper, and J. L. Malo. 1993. Airway reponsiveness: standardised challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur. Respir. J. 6(Suppl. 16):53-83.
14. 1992. Workshop summary and guidelines: investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airway diseases. Eur. Respir. J. 5:115-121.
15. Clarkson, K., C. K. Power, F. O'Connell, S. Pathmakanthan, and C. M. Burke. 1993. A comparative evaluation of propofol and midazolam as sedative agents in fiberoptic bronchoscopy. Chest 104:1029-1031.
16. Djukanovic, R., S. Homeyard, C. Gratziou, J. Madden, A. Walls, S. Montefort, D. Peroni, R. Polosa, S. Holgate, and P. Howarth. 1997. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am. J. Respir. Crit. Care Med, 155:826-832.
17. Jeffery, P. K. 1998. Investigation and assessment of airway and lung inflammation: we now have the tools, what are the questions? Eur. Respir. J. 11:524-528.
18. Fahy, J. V., and H. A. Boushey. 1998. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur. Respir. J. 11:1240-1247.
19. Barnes, P. J., and S. Pedersen. 1993. Efficacy and safety of inhaled corticosteroids in asthma. Am. Rev. Respir. Dis. 148:S1-S26.
20. Tweeddale, P. M., S. Merchant, M. Leslie, F. Alexander, and G. J. McHardy, 1984. Short-term variability in FEV1: relation to pretest activity, level of FEV1 and smoking habits. Thorax 39:928-932.
21. de Haut, P., A. Rachiele, R. R. Martin, and J. L. Malo. 1983. Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax 38:516-522.
22. Oldham, P. D., and T. J. Cole. 1983. Estimation of the FEV1. Thorax 38:662-667.